EISAI CO LTD (ESALF:OTCMKTS)

$31 -1 (-3.125%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 60

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed EISAI CO LTD (ESALF:OTCMKTS) News Sources

Eisai: Canada's Drug Agency Recommendation Denies Canadians Safer Insomnia Treatments

29-01-2026

yahoo.com

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan

05-02-2026

yahoo.com

Eisai signs $388m deal for Japanese rights to Henlius’ anti-PD-1 mAb

05-02-2026

pharmaceutical-technology.com

Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025

06-02-2026

yahoo.com

BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China

09-02-2026

yahoo.com

EISAI CO LTD (ESALF:OTCMKTS) Sentiment Trend

0 25 50 75 100 13 66 66 87 66 29-01-2026 05-02-2026 06-02-2026 09-02-2026 #1 #2 #3 #4 #5 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

EISAI CO LTD (ESALF:OTCMKTS) FAQs

toggle

What is the current price of EISAI CO LTD (ESALF:OTCMKTS)?

The current price of EISAI CO LTD (ESALF:OTCMKTS) is $31.


toggle

EISAI CO LTD (ESALF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of EISAI CO LTD (ESALF:OTCMKTS) since the previous trading day is $-1.


toggle

EISAI CO LTD (ESALF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of EISAI CO LTD (ESALF:OTCMKTS) since the previous trading day is -3.125%.


toggle

What is the most recent average sentiment score for EISAI CO LTD (ESALF:OTCMKTS)?

The most recent average sentiment score for EISAI CO LTD (ESALF:OTCMKTS) is 60 out of 100.


toggle

What is the most recent average sentiment for EISAI CO LTD (ESALF:OTCMKTS)?

The most recent sentiment for EISAI CO LTD (ESALF:OTCMKTS) is .


SEC-8K** Filing Available For EISAI CO LTD (ESALF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.